Circulation

1. Circulation12 Feb 2026

   Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design

   Cohort studyPulmonary vascular & VTE

2. Circulation11 Feb 2026

   Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association

   Guideline or statementPrevention & lipids

3. Circulation10 Feb 2026

   Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association

   Guideline or statementPrevention & lipids

4. Circulation9 Feb 2026

   Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting

   Research articleArrhythmias & EP

5. Circulation9 Feb 2026

   Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association

   Guideline or statementCardio-oncology & other

6. Circulation6 Feb 2026

   Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis

   Cohort studyHeart failure

7. Circulation6 Feb 2026

   Genome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve

   Meta-analysisValvular & structural

8. Circulation3 Feb 2026

   Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association

   Guideline or statementCoronary & ACS

9. Circulation2 Feb 2026

   Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

   Secondary analysisValvular & structural

10. Circulation30 Jan 2026

    Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin

    Meta-analysisArrhythmias & EP

11. Circulation29 Jan 2026

    Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study

    Cross-sectional studyCoronary & ACS

12. Circulation26 Jan 2026

    Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification

    Research articleAortic & peripheral

13. Circulation23 Jan 2026

    Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study

    Cohort studyCardio-oncology & other

14. Circulation22 Jan 2026

    Polycystic Ovarian Syndrome and the Long-Term Risk of Arrhythmias

    Cohort studyArrhythmias & EP

15. Circulation22 Jan 2026

    Association of Pre-Fontan Hemodynamics With Long-Term Outcomes After Fontan Palliation: A Study From the Pediatric Cardiac Care Consortium

    Cohort studyCongenital

16. Circulation21 Jan 2026

    2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

    Guideline or statementPrevention & lipids

17. Circulation15 Jan 2026

    Socioeconomic and Structural Barriers to Addressing Obesity in Communities: A Scientific Statement From the American Heart Association

    Guideline or statementCardiometabolic & kidney

18. Circulation12 Jan 2026

    Multivalve Involvement in Aortic Stenosis: Insights From a Narrative Review

    Research articleValvular & structural

19. Circulation5 Jan 2026

    Clinical Spectrum of Children With Parvovirus B19–Associated Acute Myocarditis

    Cohort studyHeart failure

20. Circulation18 Dec 2025

    2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Guideline or statementCongenital

21. Circulation18 Dec 2025

    IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

    Research articleHeart failure

22. Circulation18 Dec 2025

    Bradycardia in Athletes: Prevalence, Mechanisms, and Risks

    Cohort studyArrhythmias & EP

23. Circulation16 Dec 2025

    Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

    Guideline or statementPrevention & lipids

24. Circulation4 Dec 2025

    Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome

    Cohort studyArrhythmias & EP

25. Circulation2 Dec 2025

    Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association

    Guideline or statementCardio-oncology & other

26. Circulation1 Dec 2025

    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome

    Secondary analysisCoronary & ACS

27. Circulation24 Nov 2025

    Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade

    Cohort studyArrhythmias & EP

28. Circulation20 Nov 2025

    Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association

    Guideline or statementCoronary & ACS

29. Circulation18 Nov 2025

    Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association

    Guideline or statementCoronary & ACS

30. Circulation13 Nov 2025

    Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association

    Guideline or statementPrevention & lipids

31. Circulation13 Nov 2025

    Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial

    Randomised controlled trial

32. Circulation12 Nov 2025

    Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance

    Cohort studyValvular & structural

33. Circulation10 Nov 2025

    Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

    Randomised controlled trialHeart failure

34. Circulation10 Nov 2025

    High-Dose Versus Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis

    Secondary analysisCardio-oncology & other

35. Circulation10 Nov 2025

    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial

    Randomised controlled trialHeart failure

36. Circulation10 Nov 2025

    Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Health Care: A Science Advisory From the American Heart Association

    Guideline or statementCardio-oncology & other

37. Circulation10 Nov 2025

    State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association

    Guideline or statementCoronary & ACS

38. Circulation9 Nov 2025

    Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial

    Randomised controlled trialArrhythmias & EP

39. Circulation8 Nov 2025

    Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation

    Diagnostic or prognostic studyArrhythmias & EP

40. Circulation8 Nov 2025

    Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women

    Cohort studyCardio-oncology & other

All 628 Briefs in ExploreShowing Briefs 121–160 of 628, newest first